← Open Payments lookup

KENNETH BUCZYNSKI: Open Payments

NPI 1790704914 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$330 in 17 payments from 11 companies in 2025. Trend: 2023 $444 · 2024 $538 · 2025 $330

Food & beverage: $330
CompanyPaymentsAmount
Astellas Pharma US Inc3$68
PFIZER INC.2$44
AstraZeneca Pharmaceuticals LP2$38
ABBVIE INC.2$35
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Merck Sharp & Dohme LLC1$23
Alnylam Pharmaceuticals Inc.1$22
Rhythm Pharmaceuticals, Inc.1$20
Bayer Healthcare Pharmaceuticals Inc.1$18
Axsome Therapeutics, Inc.1$15

Products named: Veozah, JARDIANCE, TRUMENBA, ROTATEQ, GIVLAARI, UBRELVY, ELIQUIS, IMCIVREE.

Industry payments across MD — which companies pay providers there.